MYL just became more of a ‘TGDT’ company: http://www.wsj.com/articles/mylan-reaches-7-2-billion-deal-for-swedens-meda-1455140159 Mylan said the deal to buy Meda will build on its portfolio of specialty generic and over-the-counter products. The acquisition will also give Mylan access to new markets like China, Russia and the Middle East.See #msg-120456111 for related info.